Lipid-based solubilization technology via hot melt extrusion: promises and challenges

References

• Amidon GL, Lennernäs H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–420.
   PubMed Web of Science ®Google Scholar
• Ghadi R, Dand N. BCS class IV drugs: highly notorious candidates for formulation development. J Control Release. 2017;248:71–95.
   PubMed Web of Science ®Google Scholar
• H. Park E-SH, Kim M-S, Kim M-S. Current status of supersaturable self-emulsifying Drug Deliverysystems. Pharmaceutics. 2020;12(365):365.
   Google Scholar
• Singh D, Bedi N, Tiwary, et al. Tiwary, Enhancing solubility of poorly aqueous soluble drugs: critical appraisal of techniques. J Pharm Invest. 2018;48(5):509–526.
   Google Scholar
• Dhaval M, Vaghela P, Patel K, et al. Lipid-based emulsion Drug Delivery systems—a comprehensive review. Drug Deliv Transl Res. 2022;12:1616–1639.
   PubMed Web of Science ®Google Scholar
• Holmstock N, Bruyn T, Bevernage J, et al. Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine. Eur J Pharm Sci. 2013;49(1):27–32.
   PubMed Web of Science ®Google Scholar
• Gupta R, Jain V, Nagar JC, et al. Bioavailability enhancement techniques for poorly soluble drugs: a review. Asian J Pharm Res Dev. 2020;8(2):75–78.
   Google Scholar
• Dumont C, Bourgeois S, Fessi H, et al. Lipid-based nanosuspensions for oral delivery of peptides, a critical review. Int J Pharm. 2018;541(1–2):117–135.
   PubMed Web of Science ®Google Scholar
• Nakach M, Shegokar R, Authelin J-R, et al. Nano-crystalline suspensions by top down processes: review of manufacturing considerations. Drug Deliv Lett. 2018;8:184–199.
   Google Scholar
• Joseph E, Singhvi G. Chapter 4 - Multifunctional nanocrystals for cancer therapy: a potential nanocarrier. In: Grumezescu, AM, editor. Nanomater Drug Deliv Ther. William Andrew Publishing. 2019;91–116.
   Google Scholar
• Gupta D, Bhatia D, Dave V, et al. Salts of therapeutic agents: chemical, physicochemical, and biological considerations. Molecules. 2018;23(7):1719.
   Web of Science ®Google Scholar
• Alsalhi A, Ayon NJ, Coulibaly F, et al. Enhancing etoposide aqueous solubility and anticancer activity with L-Arginine. Assay Drug Dev Technol. 2021;19(8):508–525.
   PubMedGoogle Scholar
• Emami S, Siahi-Shadbad M, Adibkia K, et al. Recent advances in improving oral drug bioavailability by cocrystals. Bioimpacts. 2018;8(4):305.
   PubMed Web of Science ®Google Scholar
• Pandi P, Bulusu R, Kommineni N, et al. Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020;586:119560.
   PubMed Web of Science ®Google Scholar
• Schittny A, Huwyler J, Puchkov M. Mechanisms of increased bioavailability through amorphous solid dispersions: a review. Drug Deliv. 2020;27(1):110–127.
   PubMed Web of Science ®Google Scholar
• Ricarte RG, van Zee NJ, Li Z, et al. Recent advances in understanding the micro-and nanoscale phenomena of amorphous solid dispersions. Mol Pharm. 2019;16(10):4089–4103.
   PubMedGoogle Scholar
• Koch N, Jennotte O, Ziemons E, et al. Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods. Int J Pharm. 2022;613:121372.
   PubMedGoogle Scholar
• Kuentz M. Lipid-based formulations for oral delivery of lipophilic drugs, Drug Discovery today. Technologies. 2012;9:e97–e104.
   Google Scholar
• Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6(3):231–248.
   PubMed Web of Science ®Google Scholar
• Cannon JB, Long MA. Chapter 11 - Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery—Part II: Oral Applications. In: Liu R, editor. Water-Insoluble Drug Formulation. CRC Press. 2018;247–282.
   Google Scholar
• Parikh KJ, Sawant KK. Solubilization of vardenafil HCl in lipid-based formulations enhances its oral bioavailability in vivo: a comparative study using Tween-20 and Cremophor-EL. J Mol Liq. 2019;277:189–199.
   Web of Science ®Google Scholar
• Zhang J, Lv Y, Wang B, et al. Influence of microemulsion–mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions. Mol Pharm. 2015;12(3):695–705.
   PubMedGoogle Scholar
• Sigurdsson HH, Kirch J, Lehr C-M. Mucus as a barrier to lipophilic drugs. Int J Pharm. 2013;453(1):56–64.
   PubMed Web of Science ®Google Scholar
• Menzel C, Bernkop-Schnürch A. Enzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrier. Adv Drug Deliv Rev. 2018;124:164–174.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Bernkop-Schnürch A. Strategies for improving mucosal Drug Deliveryery. Nanomedicine. 2013;8(12):2061–2075.
   PubMed Web of Science ®Google Scholar
• Leichner C, Menzel C, Laffleur F, et al. Development and in vitro characterization of a papain loaded mucolytic self-emulsifying Drug Delivery system (SEDDS. Int J Pharm. 2017;530(1–2):346–353.
   PubMedGoogle Scholar
• Abdulkarim M, Sharma PK, Gumbleton M. Self-emulsifying Drug Delivery system: mucus permeation and innovative quantification technologies. Adv Drug Deliv Rev. 2019;142:62–74.
   PubMed Web of Science ®Google Scholar
• Griesser J, Hetényi G, Kadas H, et al. Self-emulsifying peptide Drug Delivery systems: how to make them highly mucus permeating. Int J Pharm. 2018;538(1–2):159–166.
   PubMed Web of Science ®Google Scholar
• Li AP. In vitro human cell–based experimental models for the evaluation of enteric metabolism and drug interaction potential of drugs and natural products. Drug Metab Dispos. 2020;48(10):980–992.
   PubMed Web of Science ®Google Scholar
• Elmeliegy M, Vourvahis M, Guo C, et al. Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug–drug interaction studies. Clin Pharmacokinet. 2020;59(6):699–714.
   PubMed Web of Science ®Google Scholar
• Hammann F, Gutmann H, Jecklin U, et al. Development of decision tree models for substrates, inhibitors, and inducers of p-glycoprotein. Curr Drug Metab. 2009;10(4):339–346.
   PubMed Web of Science ®Google Scholar
• Dong J, Qin Z, Zhang W-D, et al. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: an update. Drug Resist Updat. 2020;49:100681.
   PubMed Web of Science ®Google Scholar
• Srivalli KMR, Lakshmi PK. Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci. 2012;48(3):353–367.
   Web of Science ®Google Scholar
• Chang C, Bahadduri PM, Polli JE, et al. Rapid identification of P-glycoprotein substrates and inhibitors. Drug Metab Dispos. 2006;34(12):1976–1984.
   PubMed Web of Science ®Google Scholar
• Rathod S, Desai H, Patil R, et al. nonionic surfactants as a P-Glycoprotein(P-gp) efflux inhibitor for optimal Drug Delivery—A Concise outlook. AAPS PharmSciTech. 2022;23(1):1–10.
   Web of Science ®Google Scholar
• Sohi H, Ahuja A, Ahmad F, et al. Critical evaluation of permeation enhancers for oral mucosal Drug Deliveryery. Drug Dev Ind Pharm. 2010;36(3):254–282.
   PubMed Web of Science ®Google Scholar
• Maher S, Mrsny R, D.b.-a. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277–319.
   PubMed Web of Science ®Google Scholar
• Whitehead K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral Drug Deliveryery. Pharm Res. 2008;25(8):1782–1788.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gao F, Jiang S, et al. Nano-based Drug Delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism. Curr Drug Metab. 2012;13:1110–1118.
   PubMed Web of Science ®Google Scholar
• Sousa IP, Bernkop-Schnürch A. Pre-systemic metabolism of orally administered drugs and strategies to overcome it. J Control Release. 2014;192:301–309.
   PubMed Web of Science ®Google Scholar
• Thummel KE, Kunze KL, Shen DD. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. Adv Drug Deliv Rev. 1997;27(2–3):99–127.
   PubMed Web of Science ®Google Scholar
• Galetin A, Gertz M, Houston JB. Contribution of intestinal cytochrome P450-mediated metabolism to Drug-Drug inhibition and induction interactions. Drug Metab Pharmacokinet. 2010;25(1):28–47.
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Walker A, Hoffer C, et al. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Clin Pharmacol Ther. 2004;76(5):452–466.
   PubMed Web of Science ®Google Scholar
• Bylund J, Bueters T. Presystemic metabolism of AZ’0908, A novel mPGES-1 inhibitor: an in vitro and in vivo cross-species comparison. J Pharm Sci. 2013;102(3):1106–1115.
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnürch A, Krajicek ME. Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan–EDTA conjugates. J Control Release. 1998;50(1–3):215–223.
   PubMed Web of Science ®Google Scholar
• Borchard G, Lueflen HL, Coos Verhoef J, et al. Mucoadhesive polymers in peroral peptide Drug Delivery. II. carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Springer. 1995;12:1293–1298.
   Google Scholar
• Eichenbaum G, Hsu CP, Subrahmanyam V, et al. Oral coadministration of β-glucuronidase to increase exposure of extensively glucuronidated drugs that undergo enterohepatic recirculation. J Pharm Sci. 2012;101(7):2545–2556.
   PubMed Web of Science ®Google Scholar
• Gonçalves A, Nikmaram N, Roohinejad S, et al. Production, properties, and applications of solid self-emulsifying delivery systems (S-SEDS) in the food and pharmaceutical industries. Colloids Surf A Physicochem Eng Asp. 2018;538:108–126.
   Web of Science ®Google Scholar
• Porter CJH, Kaukonen AM, Boyd BJ, et al. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm Res. 2004;21(8):1405–1412.
   PubMed Web of Science ®Google Scholar
• Brocks DR, Davies NM. Lymphatic drug absorption via the enterocytes: pharmacokinetic simulation, modeling, and considerations for optimal drug development. J Pharm Pharm Sci. 2018;21(1s):254s–270s.
   PubMedGoogle Scholar
• Menzel C, Holzeisen T, Laffleur F, et al. In vivo evaluation of an oral self-emulsifying Drug Delivery system (SEDDS) for exenatide. J Control Release. 2018;277:165–172.
   PubMed Web of Science ®Google Scholar
• Schneider F, Koziolek M, Weitschies W. In vitro and in vivo test methods for the evaluation of gastroretentive dosage forms. Pharmaceutics. 2019;11(416):416. 11 (2019).
   Google Scholar
• Feeney OM, Crum MF, McEvoy CL, et al. 50 years of oral lipid-based formulations: provenance, progress and future perspectives. Adv Drug Deliv Rev. 2016;101:167–194.
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. Development of supersaturatable self-emulsifying Drug Delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3(1):97–110.
   PubMedGoogle Scholar
• Holm R, Tonsberg H, Jorgensen EB, et al. Influence of bile on the absorption of halofantrine from lipid-based formulations. Eur J Pharm Biopharm. 2012;81(2):281–287.
   PubMed Web of Science ®Google Scholar
• Zupančič O, Partenhauser A, Lam HT, et al. Development and in vitro characterization of an oral self-emulsifying delivery system for daptomycin. Eur J Pharm Sci. 2016;81:129–136.
   PubMed Web of Science ®Google Scholar
• Friedl H, Dünnhaupt S, Hintzen F, et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying Drug DeliverySystems. J Pharm Sci. 2013;102(12):4406–4413.
   PubMed Web of Science ®Google Scholar
• Dünnhaupt S, Kammona O, Waldner C, et al. Nano-carrier systems: strategies to overcome the mucus gel barrier. Eur J Pharm Biopharm. 2015;96:447–453.
   PubMed Web of Science ®Google Scholar
• Goo YT, Song SH, Yeom DW, et al. Enhanced oral bioavailability of valsartan in rats using a supersaturable self-microemulsifying. Drug Delivery system with P-glycoprotein Inhibitors. 2019;25:178–186.
   Google Scholar
• Netsomboon K, Laffleur F, Suchaoin W, et al. Novel in vitro transport method for screening the reversibility of P-glycoprotein inhibitors. Eur J Pharm Biopharm. 2016;100:9–14.
   PubMed Web of Science ®Google Scholar
• Bogman K, Erne-Brand F, Alsenz J, et al. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J Pharm Sci. 2003;92(6):1250–1261.
   PubMed Web of Science ®Google Scholar
• Twarog C, Fattah S, Heade J, et al. Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C 10. Pharmaceutics. 2019;11(2):78.
   PubMed Web of Science ®Google Scholar
• Gleeson JP, Ryan SM, Brayden DJ. Oral delivery strategies for nutraceuticals: delivery vehicles and absorption enhancers. Trends Food SciTechnol. 2016;53:90–101.
   Web of Science ®Google Scholar
• Bu P, Ji Y, Narayanan S, et al. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying Drug Delivery systems using Caco-2 cell model: polysorbate 80 as the surfactant. Eur J Pharm Sci. 2017;99:350–360.
   PubMed Web of Science ®Google Scholar
• Kossena GA, Charman WN, Wilson CG, et al. Low dose lipid formulations: effects on gastric emptying and biliary secretion. Pharm Res. 2007;24(11):2084–2096.
   PubMed Web of Science ®Google Scholar
• Brown NJ, Read NW, Richardson A, et al. Characteristics of lipid substances activating the ileal brake in the rat. Gut. 1990;31:1126–1129.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Trotman IF, Adrian TE, et al. Further characterization of the ’ileal brake’ reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut. 1988;29(8):1042–1051.
   PubMed Web of Science ®Google Scholar
• Christiansen ML, Holm R, Abrahamsson B, et al. Effect of food intake and co-administration of placebo self-nanoemulsifying Drug Delivery systems on the absorption of cinnarizine in healthy human volunteers. Eur J Pharm Sci. 2016;84:77–82.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Faham A, Clas SD, et al. Lipids and polymers in pharmaceutical technology: lifelong companions. Int J Pharm. 2019;558:128–142.
   PubMedGoogle Scholar
• Chauhan G, Shaik AA, Kulkarni NS, et al. The preparation of lipid-based Drug Delivery system using melt extrusion. Drug Discov Today. 2020;25:1930–1943.
   Web of Science ®Google Scholar
• Mesut B, Güngör S, Husuzade G. Role of self-emulsifying Drug DeliverySystems in enhancing the oral bioavailability of BCS class II drugs. Proceedings. 2021;78:32.
   Google Scholar
• Jianxian C, Saleem K, Ijaz M, et al. Development and in vitro evaluation of gastro-protective aceclofenac-loaded self-emulsifying Drug DeliverySystem. Int J Nanomedicine. 2020;15:5217.
   PubMed Web of Science ®Google Scholar
• Zakkula A, Gabani B, Jairam R, et al. Preparation and optimization of nilotinib self-micro-emulsifying Drug Delivery systems to enhance oral bioavailability. Drug Dev Ind Pharm. 2020;46(3):498–504.
   PubMed Web of Science ®Google Scholar
• Husuzade G, Mesut B, Güngor S. Development of a solid-type IV self-emulsifying Drug DeliverySystem of BCS class II drug. 1st International Electronic Conference on Pharmaceutics, Switzerland. 2020;78:32.
   Google Scholar
• Leonaviciute G, Zupančič O, Prüfert F, et al. Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs toward intestinal peptidases. Int J Pharm. 2016;508(1–2):102–108.
   PubMedGoogle Scholar
• Zupančič O, Leonaviciute G, Lam HT, et al. Development and in vitro evaluation of an oral SEDDS for desmopressin. Drug Deliv. 2016;23(6):2074–2083.
   PubMed Web of Science ®Google Scholar
• Ijaz M, Bonengel S, Zupančič O, et al. Development of oral self nano-emulsifying delivery system (s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions. Expert Opin Drug Deliv. 2016;137:923–929. 137
   PubMed Web of Science ®Google Scholar
• Zupančič O, Rohrer J, Thanh Lam H, et al. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm. 2017;43(10):1694–1702.
   PubMed Web of Science ®Google Scholar
• Nazir I, Asim MH, Dizdarević A, et al. Self-emulsifying Drug Delivery systems: impact of stability of hydrophobic ion pairs on drug release. Int J Pharm. 2019;561:197–205.
   PubMedGoogle Scholar
• Friedl JD, Jörgensen AM, Le‐Vinh B, et al. Solidification of self-emulsifying Drug Delivery systems (SEDDS): impact on storage stability of a therapeutic protein. J Colloid Interface Sci. 2021;584:684–697.
   PubMed Web of Science ®Google Scholar
• Zupančič O, Grieβinger JA, Rohrer J, et al. Development, in vitro and in vivo evaluation of a self-emulsifying Drug Delivery system (SEDDS) for oral enoxaparin administration. Eur J Pharm Biopharm. 2016;109:113–121.
   PubMed Web of Science ®Google Scholar
• Tan A, Rao S, Prestidge CA. Transforming lipid-based oral Drug Delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharm Res. 2013;30(12):2993–3017.
   PubMed Web of Science ®Google Scholar
• P. Joyce TJD, Meola TR, Schultz HB, et al. Solidification to improve the biopharmaceutical performance of SEDDS: opportunities and challenges. Adv Drug Deliv Rev. 2019;142:102–117. DOI:10.1016/j.addr.2018.11.006.
   PubMed Web of Science ®Google Scholar
• Wagh MP, Singh PK, Chaudhari CS, et al. Solid self-emulsifying Drug Delivery system: preparation techniques and dosage forms. Int J Biopharm. 2014;5:101–108.
   Google Scholar
• Tang B, Cheng G, Gu J-C, et al. Development of solid self-emulsifying Drug Delivery systems: preparation techniques and dosage forms. Drug Discov Today. 2008;13(13–14):606–612.
   PubMed Web of Science ®Google Scholar
• Jannin V, Musakhanian J, Marchaud D. Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 2008;60(6):734–746.
   PubMed Web of Science ®Google Scholar
• Maji I, Mahajan S, Sriram A, et al. Solid self emulsifying Drug Delivery system: superior mode for oral delivery of hydrophobic cargos. J Control Release. 2021;337:646–660. DOI:10.1016/j.jconrel.2021.08.013.
   PubMed Web of Science ®Google Scholar
• Sacher S, Poms J, Rehrl J, et al. PAT implementation for advanced process control in solid dosage manufacturing – a practical guide. Int J Pharm. 2022;613:121408.
   PubMedGoogle Scholar
• Passerini N, Perissutti B, Albertini B, et al. A new approach to enhance oral bioavailability of silybum marianum dry extract: association of mechanochemical activation and spray congealing. Phytomedicine. 2012;19(2):160–168.
   PubMed Web of Science ®Google Scholar
• Albertini B, Di Sabatino M, Melegari C, et al. Formulation of spray congealed microparticles with self-emulsifying ability for enhanced glibenclamide dissolution performance. J Microencapsul. 2015;32(2):181–192.
   PubMed Web of Science ®Google Scholar
• van Speybroeck M, Williams HD, Nguyen TH, et al. Incomplete Desorption of Liquid Excipients Reduces the in Vitro and in Vivo Performance of Self-Emulsifying Drug Delivery Systems Solidified by Adsorption onto an Inorganic Mesoporous Carrier. Mol Pharm. 2012;9(9):2750–2760.
   PubMedGoogle Scholar
• Maniruzzaman M, Boateng JS, Snowden MJ, et al. A review of hot-melt extrusion: process technology to pharmaceutical products. Int Sch Res Notices. 2012;2012. Article id: 436763.
   Google Scholar
• Patil H, Kulkarni V, Majumdar S, et al. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion. Int J Pharm. 2014;471(1–2):153–156.
   PubMed Web of Science ®Google Scholar
• H. Patil XF, Repka MA, Repka MA, et al. Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS J. 2015;17(1):194–205.
   PubMed Web of Science ®Google Scholar
• Shadambikar G, Marathe S, Ji N, et al. Formulation development of itraconazole PEGylated nano-lipid carriers for pulmonary aspergillosis using hot-melt extrusion technology. Int J Pharm. 2021;X(3):100074.
   Google Scholar
• Bhagurkar AM, Repka MA, Murthy SN. A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology. J Pharm Sci. 2017;106(4):1085–1091.
   PubMed Web of Science ®Google Scholar
• Witschnigg A, Koscher G, Treffer D, et al. Micro-pelletizing of pharmaceutical HME formulations using a die face pelletizer. AIP Conf Proc. 2016;1779:130001.
   Google Scholar
• Spoerk M, Kottlan A, Makert C, et al. Continuously processed micropellets by hot-melt extrusion. AAPS PharmSciTec. 2022.
   Google Scholar
• Sacher S, Celikovic S, Rehrl J, et al. Toward a novel continuous HME-`ting line: process development and control concept. Eur J Pharm Sci. 2020;142:105097.
   PubMed Web of Science ®Google Scholar
• Eggenreich K, Windhab S, Schrank S, et al. Injection molding as a one-step process for the direct production of pharmaceutical dosage forms from primary powders. Int J Pharm. 2016;505(1–2):341–351.
   PubMedGoogle Scholar
• Tan DK, Maniruzzaman M, Nokhodchi A. Advanced pharmaceutical applications of hot-melt extrusion coupled with Fused Deposition Modeling (FDM) 3D printing for personalized Drug Deliveryery. Pharmaceutics. 2018;10(4):203.
   Web of Science ®Google Scholar
• Zhang J, Feng X, Patil H, et al. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int J Pharm. 2017;519(1–2):186–197.
   PubMed Web of Science ®Google Scholar
• Ren Y, Mei L, Zhou L, et al. Recent perspectives in hot melt extrusion-based polymeric formulations for Drug Delivery: applications and Innovations. AAPS PharmSciTech. 2019;20(3):1–12.
   Web of Science ®Google Scholar
• Fan R, Chuan D, Hou H, et al. Development and evaluation of a novel biodegradable implants with excellent inflammatory response suppression effect by hot-melt extrusion. Eur J Pharm Sci. 2021;166:105981.
   PubMed Web of Science ®Google Scholar
• Sacher S, Heindl N, Afonso Urich JA, et al. A solution for low-dose feeding in continuous pharmaceutical processes. Int J Pharm. 2020;591:119969.
   PubMedGoogle Scholar
• Repka MA, Bandari S, Kallakunta VR, et al. Melt extrusion with poorly soluble drugs–An integrated review. Int J Pharm. 2018;535(1–2):68–85.
   PubMedGoogle Scholar
• Khinast J, Bresciani M. Chapter 1 - Continuous Manufacturing: Definitions and Engineering Principles. In: Kleinebudde P, Khinast J, Rantanen J, editors. Continuous manufacturing of pharmaceuticals. John Wiley & Sons; 2017. pp. 1–31.
   Google Scholar
• Kallakunta VR, Sarabu S, Bandari S, et al. An update on the contribution of hot-melt extrusion technology to novel Drug Delivery in the twenty-first century: part I. Expert Opin Drug Delivery. 2019;16(5):539–550.
   PubMed Web of Science ®Google Scholar
• Sacher S, Poms J, Rehrl J, et al. PAT implementation for advanced process control in solid dosage manufacturing – a practical guide. Int J Pharm. 2022;613:121408.
   PubMedGoogle Scholar
• Rehrl J, Karttunen AP, Nicolaï N, et al. Control of three different continuous pharmaceutical manufacturing processes: use of soft sensors. Int J Pharm. 2018;543(1–2):60–72.
   PubMedGoogle Scholar
• Rehrl J, Kirchengast M, Celikovic S, et al. Improving pellet quality in a pharmaceutical hot melt extrusion process via PID control and LOLIMOT-based MPC. J Pharm Innov. 2020;15(4):678–689.
   Web of Science ®Google Scholar
• Beretta M, Pinto JT, Laggner P, et al. Insights into the impact of nanostructural properties on powder tribocharging: the case of milled salbutamol sulfate. Mol Pharm. 2022;19(2):547–557.
   PubMedGoogle Scholar
• Koutsamanis I, Spoerk M, Arbeiter F, et al. Development of porous polyurethane implants manufactured via hot-melt extrusion. Polymers (Basel). 2020;12(12):1–22.
   Web of Science ®Google Scholar
• Kruisz J, Rehrl J, Hörmann-Kincses TR, et al. Effects of signal processing on the relative standard deviation in powder feeding characterization for continuous manufacturing. Powder Technol. 2021;389:536–548.
   Web of Science ®Google Scholar
• Fathollahi S, Sacher S, Escotet-Espinoza MS, et al. Performance evaluation of a high-precision low-dose powder feeder. AAPS PharmSciTech. 2020;21(8). DOI:10.1208/s12249-020-01835-5
   PubMed Web of Science ®Google Scholar
• Silva LAD, Almeida SL, Alonso ECP, et al. Preparation of a solid self-microemulsifying drug delivery system by hot-melt extrusion. Int J Pharm. 2018;541(1–2):1–10.
   PubMedGoogle Scholar
• Aldosari B. Development and evaluation of self-nanoemulsifying drug delivery systems for oral delivery of indomethacin. UCL (University College London); 2018.
   Google Scholar
• Gumaste SG, Gupta SS, Serajuddin ATM. Investigation of polymer-surfactant and polymer-drug-surfactant miscibility for solid dispersion. AAPS J. 2016;18(5):1131–1143.
   PubMed Web of Science ®Google Scholar
• Bordos E, Islam MT, Florence AJ, et al. Use of terahertz-raman spectroscopy to determine solubility of the crystalline active pharmaceutical ingredient in polymeric matrices during hot melt extrusion. Mol Pharm. 2019;16(10):4361–4371.
   PubMedGoogle Scholar
• Krumbholz N, Hochrein T, Vieweg N, et al. Monitoring polymeric compounding processes inline with THz time-domain spectroscopy. Polym Test. 2009;28(1):30–35.
   Web of Science ®Google Scholar
• Wietzke S, Rutz F, Jördens C, et al. Applications of terahertz spectroscopy in the plastics industry. Terahertz Photonics. 2007;6840:68400 V.
   Google Scholar
• Koutsamanis I, Paudel A, Alva Zúñiga CP, et al. Novel polyester-based thermoplastic elastomers for 3D-printed long-acting Drug Deliveryapplications. J Control Release. 2021;335:290–305.
   PubMed Web of Science ®Google Scholar
• Kushwah V, Saraf I, Yeoh T, et al. Interplay of aging and lot-to-lot variability on the physical and chemical properties of excipients: a case study of mono- and diglycerides. Mol Pharm. 2021;18(3):862–877.
   PubMedGoogle Scholar
• Kushwah V, Lopes DG, Koutsamanis I, et al. Evolution of the microstructure and the drug release upon annealing the drug loaded lipid-surfactant microspheres. Eur J Pharm Sci. 2020;147:105278.
   PubMed Web of Science ®Google Scholar
• Saraf I, Kushwah V, Weber H, et al. Quantitative chemical profiling of commercial glyceride excipients via 1 H NMR spectroscopy. AAPS PharmSciTech. 2021;22(1):1–9.
   Web of Science ®Google Scholar
• Sarabu S, Bandari S, Kallakunta VR, et al. An update on the contribution of hot-melt extrusion technology to novel Drug Delivery in the twenty-first century: part II. Expert Opin Drug Deliv. 2019;16(6):567–582.
   PubMed Web of Science ®Google Scholar
• Thakkar R, Thakkar R, Pillai A, et al. Systematic screening of pharmaceutical polymers for hot melt extrusion processing: a comprehensive review. Int J Pharm. 2020;576:118989.
   PubMedGoogle Scholar
• Li L, Yi T, Lam CWK. Effects of spray-drying and choice of solid carriers on concentrations of labrasol® and transcutol® in solid Self-Microemulsifying Drug DeliverySystems (SMEDDS. Molecules. 2013;18(2013):545–560.
   PubMedGoogle Scholar
• Abbasi S, Higashino H, Sato Y, et al. Maximizing the oral bioavailability of poorly water-soluble drugs using novel oil-like materials in lipid-based formulations. Mol Pharm. 2021;18(9):3281–3289.
   PubMedGoogle Scholar
• Wu X, Zhu Q, Chen Z, et al. Ionic liquids as a useful tool for tailoring active pharmaceutical ingredients. J Control Release. 2021;338:268–283.
   PubMed Web of Science ®Google Scholar
• accessed on 17.May.2022 https://www.peristalticpumps.it/en/tag/densi-en/
   Google Scholar
• Nardin I, Köllner S. Successful development of oral SEDDS: screening of excipients from the industrial point of view. Adv Drug Deliv Rev. 2019;142:128–140.
   PubMed Web of Science ®Google Scholar
• Hsiao CYY, Ottaway CA, Wetlaufer DB. Preparation of fully deuterated fatty acids by simple method. Lipids. 1974;9(11):913–915. 9 (1974).
   PubMed Web of Science ®Google Scholar
• Shchepinov MS. Polyunsaturated fatty acid deuteration against neurodegeneration. Trends Pharmacol Sci. 2020;41(4):236–248.
   PubMed Web of Science ®Google Scholar
• Beaudoin-Chabot C, Wang L, Smarun AV, et al. Deuterated polyunsaturated fatty acids reduce oxidative stress and extend the lifespan of C. Elegans,Front Physiol. 2019;10:641.
   PubMed Web of Science ®Google Scholar
• Firsov AM, Fomich MA, V. Bekish A, et al. Threshold protective effect of deuterated polyunsaturated fatty acids on peroxidation of lipid bilayers. FEBS J. 2019;286(11):2099–2117.
   PubMed Web of Science ®Google Scholar
• Russak E. E.B.-A. of Pharmacotherapy, undefined 2019, Impact of deuterium substitution on the pharmacokinetics of pharmaceuticals. Journals.Sagepub.Com. 2019;53:211–216.
   Google Scholar
• Crowley MM, Zhang F, Repka MA, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm. 2007;33(9):909–926.
   PubMed Web of Science ®Google Scholar
• Becker K, Salar-Behzadi S, Zimmer A. Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm Res. 2015;32(5):1519–1545.
   PubMed Web of Science ®Google Scholar
• Schulze S, Winter G. Lipid extrudates as novel sustained release systems for pharmaceutical proteins. J Control Release. 2009;134(3):177–185.
   PubMed Web of Science ®Google Scholar
• Silva L, Teixeira F, Serpa R. Evaluation of carvedilol compatibility with lipid excipients for the development of lipid-based Drug Deliverysystems. J Therm Anal Calorim. 2016;123(3):2337–2344.
   Web of Science ®Google Scholar
• Kumar N, Goindi S, Saini B, et al. Thermal characterization and compatibility studies of itraconazole and excipients for development of solid lipid nanoparticles. J Therm Anal Calorim. 2013;115(3):2375–2383.
   Web of Science ®Google Scholar
• Kaur A, Goindi S, Katare OP. Thermal analysis and quantitative characterization of compatibility between diflunisal and lipid excipients as raw materials for development of solid lipid nanoparticles. Thermochim acta. 2016;643:23–32.
   Web of Science ®Google Scholar
• Zhang N, Zhang W, Jin Y, et al. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs. Pharm Dev Technol. 2011;16(4):415–421.
   PubMed Web of Science ®Google Scholar
• Suys EJA, Chalmers DK, Pouton CW, et al. Polymeric precipitation inhibitors promote fenofibrate supersaturation and enhance drug absorption from a type IV lipid-based formulation. Mol Pharm. 2018;15(6):2355–2371.
   PubMedGoogle Scholar
• Tung NT, Tran CS, Nguyen HA, et al. Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying Drug Delivery systems containing silymarin. Int J Pharm. 2019;555:63–76.
   PubMedGoogle Scholar
• Dash RN, Mohammed H, Humaira T, et al. Solid supersaturatable self-nanoemulsifying Drug Delivery systems for improved dissolution, absorption and pharmacodynamic effects of glipizide. J Drug DeliverySci Technol. 2015;28:28–36.
   Web of Science ®Google Scholar
• Dash RN, Mohammed H, Humaira T. Design, optimization, and evaluation of ezetimibe solid supersaturatable self-nanoemulsifying Drug Delivery for enhanced solubility and dissolution. J Pharm Invest. 2015;46(2):153–168. 46 (2015).
   Google Scholar
• Anby MU, Williams HD, McIntosh M, et al. Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying Drug DeliverySystems. Mol Pharm. 2012;9(7):2063–2079.
   PubMedGoogle Scholar
• Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003;92(12):2386–2398.
   PubMed Web of Science ®Google Scholar
• Shi Y, Gao P, Gong Y, et al. Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption. Mol Pharm. 2010;7(5):1458–1465.
   PubMedGoogle Scholar
• Jaisamut P, Wiwattanawongsa K, Graidist P, et al. Enhanced oral bioavailability of curcumin using a supersaturatable self-microemulsifying system incorporating a hydrophilic polymer; in vitro and in vivo investigations. AAPS PharmSciTech. 2017;19(2):730–740. 19 (2017).
   PubMed Web of Science ®Google Scholar
• Gosangari S, Dyakonov T. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations. Pharm Dev Technol. 2013;18(2):475–480.
   PubMed Web of Science ®Google Scholar
• Chavan RB, Modi SR, Bansal AK. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib. Int J Pharm. 2015;495(1):374–384.
   PubMedGoogle Scholar
• Song WH, Yeom DW, Lee DH, et al. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying Drug Deliverysystem. Arch Pharm Res. 2014;37(5):626–635.
   PubMed Web of Science ®Google Scholar
• Song WH, Park JH, Yeom DW, et al. Enhanced dissolution of celecoxib by supersaturating self-emulsifying Drug Delivery system (S-SEDDS) formulation. Arch Pharm Res. 2013;36(1):69–78.
   PubMed Web of Science ®Google Scholar
• Lee DR, Ho MJ, Jung HJ, et al. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying Drug Deliverysystem. Int J Nanomedicine. 2016;11:1109–1117.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim HH, Cho YH, et al. Development and evaluation of raloxifene-hydrochloride-loaded supersaturatable SMEDDS containing an acidifier. Pharmaceutics. 2018;10(78):78.
   Google Scholar
• Chapman D. The polymorphism of glycerides. Chem Rev. 1962;62(5):433–456.
   Web of Science ®Google Scholar
• Sato K. Crystallization behavior of fats and lipids—a review. Chem Eng Sci. 2001;56(7):2255–2265.
   Web of Science ®Google Scholar
• Lutton ES. Review of the polymorphism of saturated even glycerides. J Am Oil Chem’ Soc. 1950;27(7):276–281.
   Web of Science ®Google Scholar
• Himawan C, Starov V, Stapley AGF. Thermodynamic and kinetic aspects of fat crystallization. Adv Colloid Interface Sci. 2006;122(1–3):1–3. 3–33.
   Web of Science ®Google Scholar
• Ghotra BS, Dyal SD, Narine SS. Lipid shortenings: a review. Food Res Int. 2002;35(10):1015–1048.
   Web of Science ®Google Scholar
• Bertoni S, Passerini N, Albertini B. Liquid lipids act as polymorphic modifiers of tristearin-based formulations produced by melting technologies. Pharmaceutics. 2021;13(7):1089.
   PubMed Web of Science ®Google Scholar
• Brunsteiner M, Khinast J, Paudel A. Relative contributions of solubility and mobility to the stability of amorphous solid dispersions of poorly soluble drugs: a molecular dynamics simulation study. Pharmaceutics. 2018;10(3):101.
   Web of Science ®Google Scholar
• Iosio T, Voinovich D, Grassi M, et al. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption. Eur J Pharm Biopharm. 2008;69(2):686–697.
   PubMed Web of Science ®Google Scholar
• Abdalla A, Klein S, Mäder K. A new self-emulsifying Drug Delivery system (SEDDS) for poorly soluble drugs: characterization, dissolution, in vitro digestion and incorporation into solid pellets. Eur J Pharm Sci. 2008;35(5):457–464.
   PubMed Web of Science ®Google Scholar
• Hülsmann S, Backensfeld T, Keitel S, et al. Melt extrusion–an alternative method for enhancing the dissolution rate of 17β-estradiol hemihydrate. Eur J Pharm Biopharm. 2000;49(3):237–242.
   PubMed Web of Science ®Google Scholar
• Serratoni M, Newton M, Booth S, et al. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur J Pharm Biopharm. 2007;65(1):94–98.
   PubMed Web of Science ®Google Scholar
• Iosio T, Voinovich D, Perissutti B, et al. Pinto Oral bioavailability of silymarin phytocomplex formulated as self-emulsifying pellets. Phytomedicine. 2011;18(6):505–512.
   PubMed Web of Science ®Google Scholar
• Nikolakakis I, Malamataris S. Self-Emulsifying pellets: relations between kinetic parameters of drug release and emulsion reconstitution—influence of formulation variables. J Pharm Sci. 2014;103(5):1453–1465.
   PubMed Web of Science ®Google Scholar
• Kate L, Gokarna V, Borhade V, et al. Bioavailability enhancement of atovaquone using hot melt extrusion technology. Eur J Pharm Sci. 2016;86:103–114.
   PubMed Web of Science ®Google Scholar
• Diril M, Karasulu Y, Toskas M, et al. Development and permeability testing of self-emulsifying atorvastatin calcium pellets and tablets of compressed pellets. Processes. 2019;7(6):365.
   Web of Science ®Google Scholar
• Newton M, Petersson J, Podczeck F, et al. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci. 2001;90(8):987–995.
   PubMed Web of Science ®Google Scholar
• Abdalla A, Mäder K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66(2):220–226.
   PubMed Web of Science ®Google Scholar
• Miao Y, Chen G, Ren L, et al. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect. Drug Deliv. 2016;23(7):2163–2172.
   PubMed Web of Science ®Google Scholar
• Hanada M, Jermain SV, Thompson SA, et al. Ternary amorphous solid dispersions containing a high-viscosity polymer and mesoporous silica enhance dissolution performance. Mol Pharm. 2021;18(1):198–213.
   PubMedGoogle Scholar
• Solomon S, Iqbal J, Albadarin AB. Insights into the ameliorating ability of mesoporous silica in modulating drug release in ternary amorphous solid dispersion prepared by hot melt extrusion. Eur J Pharm Biopharm. 2021;165:244–258.
   PubMed Web of Science ®Google Scholar
• Albertini B, Perissutti B, Bertoni S, et al. Combining mechanochemistry and spray congealing for new praziquantel pediatric formulations in schistosomiasis treatment. Int J Mol Sci. 2019;20(5):1233.
   Web of Science ®Google Scholar
• Khinast J, Baumgartner R, Roblegg E. Nano-extrusion: a one-step process for manufacturing of solid nanoparticle formulations directly from the liquid phase. AAPS PharmSciTech. 2013;14(2):601–604. 14 (2013).
   PubMed Web of Science ®Google Scholar
• Baumgartner R, Matić J, Schrank S, et al. NANEX: process design and optimization. Int J Pharm. 2016;506(1–2):35–45.
   PubMedGoogle Scholar
• Brinkmann J, Luebbert C, Zaitsau DH, et al. Thermodynamic modeling of triglycerides using PC-SAFT. J Chem Eng Data. 2019;64(4):1446–1453.
   Web of Science ®Google Scholar
• Luebbert C, Brinkmann J, Exner L, et al. PC-SAFT Modeling of Phase Equilibria Relevant for Lipid-Based Drug DeliverySystems. J Chem Eng Data. 2021;66(3):1280–1289.
   Web of Science ®Google Scholar
• Matić J, Alva C, Eder S, et al. Toward predicting the product quality in hot-melt extrusion: pilot plant scale extrusion. Int J Pharm. 2021;X(3):100084.
   Google Scholar
• Matić J, Alva C, Witschnigg A, et al. Toward predicting the product quality in hot-melt extrusion: small scale extrusion. Int J Pharm. 2020;X(2):100062.
   Google Scholar
• Salentinig S, Amenitsch H, Yaghmur A. In situ monitoring of nanostructure formation during the digestion of mayonnaise. ACS Omega. 2017;2(4):1441–1446.
   PubMed Web of Science ®Google Scholar
• Boyd BJ, Clulow AJ. The influence of lipid digestion on the fate of orally administered Drug Deliveryvehicles. Biochem Soc Trans. 2021;49(4):1749–1761.
   PubMed Web of Science ®Google Scholar
• Ben Messaoud G, le Griel P, Hermida-Merino D, et al. Effects of pH, temperature and shear on the structure–property relationship of lamellar hydrogels from microbial glucolipids probed by in sit rheo-SAXS. Soft Matter. 2020;16(10):2540–2551.
   PubMed Web of Science ®Google Scholar
• Wang R, Jin W, Huang X. Construction of zwitterionic surfactant-stabilized hydrophobic ionic liquid-based bicontinuous microemulsion and microstructure-dependent activity of solubilized lipase. J Mol Liq. 2020;317:114011.
   Web of Science ®Google Scholar
• Goswami D. Lipase Catalysis in Presence of Nonionic Surfactants. Appl Biochem Biotechnol. 2019;191(2):744–762.
   PubMed Web of Science ®Google Scholar